Finding potential serious adverse events of drugs by using clinical trial data and machine learning tools

Download

VBugraDemirMscThesis.pdf

Date

2021-12-30

Author

Demir, Veysel Buğra

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

331
views

213
downloads

Healthcare is improving day by day and these developments make healthcare more accessible and this leads to production of large amount of data. The interpretation of these data, making assumptions and revealing significant results by using data analysis methods are important here as in every field that produces big data. Analysed data that are collected during clinical trials have great effect in ensuring developments in healthcare. Adverse event reports are one of the important parts of the clinically studied drugs or treatments. Evaluating the safety of an anticancer treatment through serious adverse events in clinical practice can provide important information for future cancer treatments. In this study, we propose a method to discover the links between serious adverse events and drugs, and between serious adverse events themselves. Our hypothesis is that, it can be possible to estimate the drug specific serious adverse events that occur together by using the clinical trial data that are transformed into a table structure for turning data into information to provide significant insights. We used ClinicalTrials.gov to download the clinical trial results that reported serious adverse events and in particular studied the anticancer drugs Cytarabine, Sorafenib and Doxorubicin. We used the MeSH and the CTCAE thesaurus to assign unique IDs to the serious adverse events to handle the inconsistency in the reports of serious adverse events. t-SNE and DBSCAN combination was used to find similar serious adverse events. To cluster the serious adverse events based on the drugs, we used spectral co-clustering. With the help of the hierarchical structure of the thesaurus, the p-values of the root and parent events were calculated to find significant ones that are encountered more or less, relatively, in a specific drug. Most of the results of this study are compatible with the available sources in the literature and the approach provided could predict the serious adverse events that are specific to new treatment options.

Subject Keywords

Serious Adverse Events, Clinical Trials, Anticancer Drugs, Data Analysis, Clustering Algorithms

URI

https://hdl.handle.net/11511/95232

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

Assessing hospital information systems processes: a validation of prise information systems success model in healthcare Ozkan, Sevgi; Baykal, Nazife; Sincan, Murat (null; 2008-12-01) Although there is limited research and evidence base, it is reasonable to expect that high quality information technology is an integral factor in the success of today’s health care sector. However, the health care sector is considered to be low level investor in Information Technology (IT) when compared to other sectors. There are studies that look at the sums spent on health IT as a basis for determining how effective the IT systems are. We support the idea that the effectiveness of IT systems, is not an ...
Towards an Evidence-Based Decision Support Tool for Management of Musculoskeletal Conditions Yet, Barbaros; Morrissey, Dylan (2018-01-01) Musculoskeletal (MSK) problems present an increasing burden for the healthcare sector, particularly in ageing populations. Advances in evidence are often slow to influence clinical decisions, suggesting decision support would be beneficial. We propose a Bayesian network (BN) for providing evidence-based decision support as it can explicitly represent domain knowledge as causal relations and allows both domain knowledge and clinical data to be combined to create a usable decision model. We make a preliminary...
Predictive Maintenance in Healthcare Services with Big Data Technologies Coban, Selin; Gökalp, Mert Onuralp; Gökalp, Ebru; Eren, Pekin Erhan; Koçyiğit, Altan (2018-11-22) Advances in medical technology is not sufficient alone to satisfy the growing and emerging needs such as improving quality of life, providing healthcare services tailored to each individual, ensuring efficient management of care and creating sustainable social healthcare. There is a potential for substantially enhancing healthcare services by integrating information technologies, social networking technologies, digitization and control of biomedical devices, and utilization of big data technologies as well ...
Measuring healthcare process quality: Applications in public hospitals in Turkey Yildiz, Ozkan; Demirörs, Onur (2013-03-01) Process improvement activities are becoming an essential part of a number of healthcare organizations. As the popularity of process improvement grows, the need for common objective measures is becoming more critical. Numerous quality measures have been suggested to evaluate healthcare quality. However, applications utilizing the existing quality measures mostly focus on the quality of specific diseases, clinics or clinical areas. Although these measures or measurement sets contain structure, process or outp...
An agent-based alert distribution system for intelligent healthcare monitoring Akçay, Buğrahan; Doğaç, Asuman; Department of Computer Engineering (2006) With the high-level developments in the information technologies, there is a big movement in the e-health area both to give better healthcare services and to reduce cost. Monitoring the patients from their home location is one of the important branches of e-health with the aging societies. In this work, an agentbased alert system is introduced which analyzes the alert message requests and sends the alert messages within the appropriate structure and communication channel to the related healthcare user. A gu...

Citation Formats

V. B. Demir, “Finding potential serious adverse events of drugs by using clinical trial data and machine learning tools,” M.S. - Master of Science, Middle East Technical University, 2021.